Unveiling Ashland (ASH) Q4 Outlook: Wall Street Estimates for Key MetricsZacks Investment Research • 11/05/24
Ashland (ASH) Reports Next Week: Wall Street Expects Earnings GrowthZacks Investment Research • 10/30/24
Ashland sets date for fourth-quarter fiscal 2024 earnings release and conference call webcastGlobeNewsWire • 10/28/24
D.A. Davidson Acts as Exclusive Financial Advisor to Turnspire Capital Partners for Debt Financing in Support of Turnspire's Acquisition of PharmachemBusiness Wire • 09/19/24
Ashland Wraps Up Nutraceuticals Business Sale to Turnspire AffiliateZacks Investment Research • 09/04/24
Pharmachem Innovations Launches as a Leading Independent Provider of Nutraceuticals Products and SolutionsBusiness Wire • 09/03/24
Ashland reports financial results1 for third quarter fiscal 2024, issues outlook for fourth quarter and full-year fiscal 2024GlobeNewsWire • 08/06/24
Ashland (ASH) Upgraded to Strong Buy: What Does It Mean for the Stock?Zacks Investment Research • 07/31/24
Ashland sets date for fiscal 2024 third-quarter earnings release and conference call webcastGlobeNewsWire • 07/17/24